Eritropoetinterápia
Eritropoetinterapia refers to the therapeutic use of erythropoietin, a hormone produced primarily by the kidneys. Erythropoietin stimulates the bone marrow to produce red blood cells. This therapy is most commonly used to treat anemia, a condition characterized by a deficiency of red blood cells.
The main indication for erythropoietin therapy is anemia associated with chronic kidney disease (CKD). In individuals
Another significant use of erythropoietin is in patients undergoing chemotherapy. Certain chemotherapy drugs can suppress bone
Erythropoietin is typically administered via subcutaneous injection or intravenously. The dosage and frequency of administration are